NSRX
Nasus Pharma Ltd (NSRX)
Healthcare • NYSE MKT • $3.15-7.08%
- Symbol
- NSRX
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Price
- $3.15
- Daily Change
- -7.08%
- Market Cap
- $36.89M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $9.99
- 52W Low
- $1.98
- Analyst Target
- $20.00
- Dividend Yield
- N/A
- Beta
- N/A
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Company websiteResearch NSRX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.